id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3528125,97f53de5-92ac-485e-8e52-75320aeafe00,Q1,BGR GOVERNMENT AFFAIRS,5357,"NEUROCRINE BIOSCIENCES, INC.",2026,first_quarter,PHA,Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2026-01-12T09:26:54-05:00
3528127,9b25d84e-e453-45cb-a198-0491ca121cd7,Q1,BGR GOVERNMENT AFFAIRS,5357,WALGREEN CO.,2026,first_quarter,PHA,"Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2026-01-12T09:36:26-05:00